Vlad Coric, Chief Executive Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 98,459 shares at $35.01 ($3.4M) on 2018-05-31, disclosed to the SEC on 2018-06-01.
Open-market sale of $3.4M BHVN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 741 | $26K | 0.8% |
| 2 | $35.00 | 800 | $28K | 0.8% |
| 3 | $35.01 | 15,648 | $548K | 15.9% |
| 4 | $35.01 | 15,648 | $548K | 15.9% |
| 5 | $35.01 | 18,971 | $664K | 19.3% |
| 6 | $35.01 | 18,971 |
| $664K |
| 19.3% |
| 7 | $35.04 | 5,229 | $183K | 5.3% |
| 8 | $35.04 | 5,229 | $183K | 5.3% |
| 9 | $35.04 | 8,611 | $302K | 8.8% |
| 10 | $35.04 | 8,611 | $302K | 8.8% |
| Total | $35.02 avg | 98,459 | $3.4M | 100% |
| Filing → |
| BHVN | BUY | 2024-10-03 | $1000K | — | Filing → |
| BHVN | BUY | 2024-04-23 | $5.0M | — | Filing → |
| BHVN | BUY | 2023-10-10 | $10.0M | — | Filing → |